Development of Sustained Release “NanoFDC (Fixed Dose Combination)” for Hypertension – An Experimental Study

OBJECTIVES: The present study was planned to formulate, characterize and evaluate the pharmacokinetics of a novel “NanoFDC” comprising three commonly prescribed anti-hypertensive drugs, hydrochlorothiazide (a diuretic), candesartan (ARB) and amlodipine (a calcium channel blocker). BASIC METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Anjuman, Shafiq, Nusrat, Jain, Sanjay, Khuller, G. K., Sharma, Sadhana, Malhotra, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457799/
https://www.ncbi.nlm.nih.gov/pubmed/26047011
http://dx.doi.org/10.1371/journal.pone.0128208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457799/
https://www.ncbi.nlm.nih.gov/pubmed/26047011
http://dx.doi.org/10.1371/journal.pone.0128208

Ejemplares similares